Home/Filings/4/0001209191-23-001018
4//SEC Filing

Loewen Andrea 4

Accession 0001209191-23-001018

CIK 0001358762other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 4:50 PM ET

Size

7.2 KB

Accession

0001209191-23-001018

Insider Transaction Report

Form 4
Period: 2023-01-03
Loewen Andrea
SVP, Global Regulatory Affairs
Transactions
  • Award

    Class A common stock

    2023-01-03+11,75644,612 total
  • Award

    Employee Stock Option (right-to-buy)

    2023-01-03+47,73847,738 total
    Exercise: $36.71Exp: 2033-01-03Class A common stock (47,738 underlying)
Footnotes (2)
  • [F1]The shares represent Restricted Stock Units, which vest 1/16th of each grant on March 6, May 15, August 15, and November 15 of each year, subject to continued service through each vesting date.
  • [F2]The options vest 1/16th of each grant on March 6, May 15, August 15, and November 15 of each year, subject to continued service through each vesting date.

Issuer

REATA PHARMACEUTICALS INC

CIK 0001358762

Entity typeother

Related Parties

1
  • filerCIK 0001591100

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:50 PM ET
Size
7.2 KB